Biopsy Devices Market
Biopsy Devices Market
$4,750.00
Symptomatic benign prostatic hyperplasia (BPH) and prostatitis affect more than 100 million men worldwide, lowering quality of life with painful symptoms that can be difficult to manage.
Publisher: Pharma Intelligence
- Description
- Contents
- Samples
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for biopsy devices.
Visit Meddevicetracker to view the latest analysis and updates for the biopsy devices market.
Topics Covered Include:
- An overview of biopsy devices, including biopsy guidance systems, needle-based biopsy products, and other biopsy devices (biopsy forceps, curettes, and shave/punch biopsy products).
- Global and country/region-specific market forecasts, including forecasts by product segment.
- Competitive analyses by product segment. • Discussion of key drivers and limiters to the biopsy devices market.
- Country and region-specific insights that are shaping the biopsy devices market.
Report Highlights
- Biopsy devices are most commonly utilized in the diagnosis of cancer. The global incidence of cancer continues to increase, driving sales of biopsy devices.
- Biopsy guidance system sales are expected to account for the largest share of total market sales, while the needle-based biopsy devices segment will register the largest growth.
- The market for biopsy devices is anticipated to experience healthy growth during the forecast period (2016-21), increasing to an estimated $2.3bn by 2021.
- Sophisticated biopsy devices are driving market growth. Biopsy guidance systems and vacuum-assisted biopsy devices are anticipated to remain major contributors to total market growth due to these devices improving the quality of tissue samples acquired and reducing procedure times and patient complications.
- The US market for biopsy devices accounted for approximately 48% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK).
- The strongest growth in biopsy product sales is expected to occur in the Rest of the World market segment, which is being driven by demand for more sophisticated healthcare services in emerging markets.
Biopsy Devices Market Table of Contents
#MDT17005
EXECUTIVE SUMMARY …………………………………………………………………………. ES-1
i. Methodology ……………………………………………………………………….. ES-5
Exhibit ES-1: Global biopsy devices market, share by country/region, 2016 ……. ES-3
Exhibit ES-2: Global biopsy devices market, share by product type, 2016 ………. ES-4
1. CANCER STATISTICS UPDATE ………………………………………………………. 1-1
1.1 Cancer prevalence and mortality ………………………………………………. 1-1
1.2 Bibliography …………………………………………………………………………. 1-10
Exhibit 1-1: Age-standardized cancer incidence and mortality cases (000s), 2012 …………………………………………………… 1-3
Exhibit 1-2: Highest age-standardized rates for all cancers, top 10 countries, 2012 …………………………………………………………………. 1-5
Exhibit 1-3: Age-standardized rates of cancer, select countries, 2012 …………….. 1-6
Exhibit 1-4: Estimated incidence of the five most common cancer types worldwide, 2012 ……………………………………………………………. 1-8
Exhibit 1-5: Estimated number of cancer deaths, select countries, 2012 …………. 1-9
2. BIOPSY DEVICES AND BIOPSY GUIDANCE SYSTEMS…………………….. 2-1
2.1 Core needle biopsy …………………………………………………………………. 2-3
2.1.1 Products …………………………………………………………………. 2-3
2.2 Fine needle aspiration biopsy …………………………………………………… 2-5
2.2.1 Products …………………………………………………………………. 2-5
2.3 Vacuum-assisted biopsy ………………………………………………………….. 2-7
2.3.1 Products …………………………………………………………………. 2-7
2.4 Endoscopic biopsy………………………………………………………………….. 2-8
2.5 Open/surgical biopsy …………………………………………………………….. 2-10
2.6 Bone and bone marrow biopsy ……………………………………………….. 2-10
2.6.1 Products ……………………………………………………………….. 2-11
2.7 Other types of biopsy products ……………………………………………….. 2-11
2.8 Biopsy guidance systems ………………………………………………………. 2-13
2.8.1 Products ……………………………………………………………….. 2-15
2.9 Emerging products/technologies …………………………………………….. 2-16
2.10 Bibliography …………………………………………………………………………. 2-19
Exhibit 2-1: Select images of core needle biopsy devices ……………………………… 2-4
Exhibit 2-2: Select images of fine needle aspiration devices ………………………….. 2-6
Exhibit 2-3: Select images of vacuum-assisted biopsy devices ………………………. 2-9
Exhibit 2-4: Select images of bone and bone marrow biopsy devices ……………. 2-12
Exhibit 2-5: Select images of biopsy forceps ……………………………………………… 2-14
Exhibit 2-6: Select images of biopsy guidance systems ………………………………. 2-17
3. BIOPSY PRODUCTS MARKET ………………………………………………………… 3-1
3.1 Global competitors ………………………………………………………………… 3-12
3.1.1 Biopsy guidance systems competitive analysis …………… 3-12
3.1.2 Needle-based biopsy products competitive analysis ……. 3-14
3.2 Market forecast: US ………………………………………………………………. 3-16
3.2.1 Biopsy guidance systems market: US ……………………….. 3-20
3.2.2 Needle-based biopsy products market: US ………………… 3-21
3.2.2.1 Competitors …………………………………………….. 3-24
3.2.3 Other biopsy products market: US ……………………………. 3-24
3.3 Market forecast: five major EU markets ……………………………………. 3-24
3.3.1 Biopsy guidance systems market: five major EU markets ……………………………………………………………. 3-28
3.3.2 Needle-based biopsy products market: five major EU markets …………………………………………………………………. 3-30
3.3.2.1 Competitors …………………………………………….. 3-32
3.3.3 Other biopsy products market: five major EU markets …. 3-32
3.4 Market forecast: Japan ………………………………………………………….. 3-35
3.4.1 Biopsy guidance systems market: Japan …………………… 3-38
3.4.2 Needle-based biopsy products market: Japan ……………. 3-39
3.4.2.1 Competitors …………………………………………….. 3-42
3.4.3 Other biopsy products market: Japan ………………………… 3-42
3.5 Market forecast: RoW ……………………………………………………………. 3-42
3.5.1 Biopsy guidance systems market: RoW …………………….. 3-47
3.5.2 Needle-based biopsy products market: RoW ……………… 3-48
3.5.2.1 Competitors …………………………………………….. 3-50
3.5.3 Other biopsy products market: RoW …………………………. 3-53
3.6 Bibliography …………………………………………………………………………. 3-55
Exhibit 3-1: Biopsy products, global market forecast, 2016-21 ……………………….. 3-2
Exhibit 3-2: Global biopsy product sales by product segment, combined market forecast ($m), 2016-21 ……………………………………………………………. 3-3
Exhibit 3-3: Average sale price for biopsy products ………………………………………. 3-5
Exhibit 3-4: Total biopsy product sales by end-user, combined market forecast ($m), 2016-21 ………………………………………………………………………… 3-8
Exhibit 3-5: Global biopsy product sales by country/region, combined market forecast ($m), 2016-21 ………………………………………………………….. 3-10
Exhibit 3-6: Global biopsy products market, share by country/region, 2016 ……. 3-13
Exhibit 3-7: Global biopsy guidance systems market, share by supplier, 2016 ………………………………………………………………….. 3-15
Exhibit 3-8: Global needle-based biopsy products market, share by supplier, 2016 ………………………………………………………………….. 3-17
Exhibit 3-9: US biopsy products, combined market forecast, 2016-21 …………… 3-19
Exhibit 3-10: US biopsy guidance systems, market forecast, 2016-21 …………….. 3-22
Exhibit 3-11: US needle-based biopsy products, market forecast, 2016-21 ……… 3-23
Exhibit 3-12: US needle-based biopsy products market, share by supplier, 2016 ………………………………………………………………….. 3-25
Exhibit 3-13: US other biopsy products, market forecast, 2016-21………………….. 3-26
Exhibit 3-14: Five major EU markets biopsy products, combined market forecast, 2016-21 …………………………………………………………………. 3-29
Exhibit 3-15: Five major EU markets biopsy guidance systems, market forecast, 2016-21 …………………………………………………………………. 3-31
Exhibit 3-16: Five major EU markets needle-based biopsy products, market forecast, 2016-21 …………………………………………………………………. 3-33
Exhibit 3-17: Five major EU markets needle-based biopsy products market, share by supplier, 2016 …………………………………………………………. 3-34
Exhibit 3-18: Five major EU markets other biopsy products, market forecast, 2016-21 …………………………………………………………………. 3-36
Exhibit 3-19: Japan biopsy products, combined market forecast, 2016-21 ………. 3-37
Exhibit 3-20: Japan biopsy guidance systems, market forecast, 2016-21 ………… 3-40
Exhibit 3-21: Japan needle-based biopsy products, market forecast, 2016-21 …. 3-41
Exhibit 3-22: Japan needle-based biopsy products market, share by supplier, 2016 ………………………………………………………………….. 3-43
Exhibit 3-23: Japan other biopsy products, market forecast, 2016-21 ……………… 3-44
Exhibit 3-24: Rest of the World biopsy products, combined market forecast, 2016-21 …………………………………………………………………. 3-46
Exhibit 3-25: Rest of the World biopsy guidance systems, market forecast, 2016-21 …………………………………………………………………. 3-49
Exhibit 3-26: Rest of the World needle-based biopsy products, market forecast, 2016-21 …………………………………………………………………. 3-51
Exhibit 3-27: Rest of World needle-based biopsy products market, share by supplier, 2016 ………………………………………………………………….. 3-52
Exhibit 3-28: Rest of the World other biopsy products, market forecast, 2016-21 …………………………………………………………………. 3-54
APPENDIX: COMPANY LISTING ……………………………..A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
LT-02 
Sign up to the